Cedric O'Gorman - 06 Jan 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Medical Officer
Signature
/s/ Cedric O'Gorman
Issuer symbol
RLMD
Transactions as of
06 Jan 2023
Net transactions value
$0
Form type
4
Filing time
13 Jan 2023, 16:54:59 UTC
Next filing
24 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 -400,000 -50% $0.000000 400,000 06 Jan 2023 Common stock 400,000 $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in 16 equal quarterly installments commencing on April 6, 2023.